Brazil · Delayed Price · Currency is BRL Raia Drogasil Statistics
Total Valuation
Raia Drogasil has a market cap or net worth of BRL 30.28 billion. The enterprise value is 38.44 billion.
| Market Cap | 30.28B |
| Enterprise Value | 38.44B |
Important Dates
The next confirmed earnings date is Tuesday, August 4, 2026.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | Jul 6, 2026 |
Share Statistics
Raia Drogasil has 1.75 billion shares outstanding. The number of shares has decreased by -1.47% in one year.
| Current Share Class | 1.75B |
| Shares Outstanding | 1.75B |
| Shares Change (YoY) | -1.47% |
| Shares Change (QoQ) | +9.05% |
| Owned by Insiders (%) | 18.88% |
| Owned by Institutions (%) | 48.06% |
| Float | 1.31B |
Valuation Ratios
The trailing PE ratio is 22.07 and the forward PE ratio is 17.50. Raia Drogasil's PEG ratio is 0.77.
| PE Ratio | 22.07 |
| Forward PE | 17.50 |
| PS Ratio | 0.66 |
| PB Ratio | 4.13 |
| P/TBV Ratio | 5.68 |
| P/FCF Ratio | 23.54 |
| P/OCF Ratio | 11.30 |
| PEG Ratio | 0.77 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 8.38, with an EV/FCF ratio of 29.88.
| EV / Earnings | 29.76 |
| EV / Sales | 0.84 |
| EV / EBITDA | 8.38 |
| EV / EBIT | 14.49 |
| EV / FCF | 29.88 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 1.18.
| Current Ratio | 1.47 |
| Quick Ratio | 0.43 |
| Debt / Equity | 1.18 |
| Debt / EBITDA | 1.90 |
| Debt / FCF | 6.76 |
| Interest Coverage | 2.30 |
Financial Efficiency
Return on equity (ROE) is 18.86% and return on invested capital (ROIC) is 15.77%.
| Return on Equity (ROE) | 18.86% |
| Return on Assets (ROA) | 6.92% |
| Return on Invested Capital (ROIC) | 15.77% |
| Return on Capital Employed (ROCE) | 17.89% |
| Weighted Average Cost of Capital (WACC) | 6.15% |
| Revenue Per Employee | 605,746 |
| Profits Per Employee | 17,181 |
| Employee Count | 75,190 |
| Asset Turnover | 1.90 |
| Inventory Turnover | 3.76 |
Taxes
In the past 12 months, Raia Drogasil has paid 104.18 million in taxes.
| Income Tax | 104.18M |
| Effective Tax Rate | 7.39% |
Stock Price Statistics
The stock price has increased by +19.69% in the last 52 weeks. The beta is 0.03, so Raia Drogasil's price volatility has been lower than the market average.
| Beta (5Y) | 0.03 |
| 52-Week Price Change | +19.69% |
| 50-Day Moving Average | 18.53 |
| 200-Day Moving Average | 21.57 |
| Relative Strength Index (RSI) | 46.21 |
| Average Volume (20 Days) | 9,473,890 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Raia Drogasil had revenue of BRL 45.55 billion and earned 1.29 billion in profits. Earnings per share was 0.78.
| Revenue | 45.55B |
| Gross Profit | 13.54B |
| Operating Income | 2.65B |
| Pretax Income | 1.41B |
| Net Income | 1.29B |
| EBITDA | 3.52B |
| EBIT | 2.65B |
| Earnings Per Share (EPS) | 0.78 |
Balance Sheet
The company has 537.74 million in cash and 8.69 billion in debt, with a net cash position of -8.16 billion or -4.66 per share.
| Cash & Cash Equivalents | 537.74M |
| Total Debt | 8.69B |
| Net Cash | -8.16B |
| Net Cash Per Share | -4.66 |
| Equity (Book Value) | 7.34B |
| Book Value Per Share | 4.20 |
| Working Capital | 4.90B |
Cash Flow
In the last 12 months, operating cash flow was 2.68 billion and capital expenditures -1.39 billion, giving a free cash flow of 1.29 billion.
| Operating Cash Flow | 2.68B |
| Capital Expenditures | -1.39B |
| Depreciation & Amortization | 866.30M |
| Net Borrowing | -555.54M |
| Free Cash Flow | 1.29B |
| FCF Per Share | 0.74 |
Margins
Gross margin is 29.72%, with operating and profit margins of 5.82% and 2.84%.
| Gross Margin | 29.72% |
| Operating Margin | 5.82% |
| Pretax Margin | 3.09% |
| Profit Margin | 2.84% |
| EBITDA Margin | 7.72% |
| EBIT Margin | 5.82% |
| FCF Margin | 2.82% |
Dividends & Yields
This stock pays an annual dividend of 0.39, which amounts to a dividend yield of 2.23%.
| Dividend Per Share | 0.39 |
| Dividend Yield | 2.23% |
| Dividend Growth (YoY) | 10.16% |
| Years of Dividend Growth | 12 |
| Payout Ratio | 50.56% |
| Buyback Yield | 1.47% |
| Shareholder Yield | 3.70% |
| Earnings Yield | 4.27% |
| FCF Yield | 4.25% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for Raia Drogasil is 26.05, which is 50.40% higher than the current price. The consensus rating is "Buy".
| Price Target | 26.05 |
| Price Target Difference | 50.40% |
| Analyst Consensus | Buy |
| Analyst Count | 15 |
| Revenue Growth Forecast (3Y) | 10.45% |
| EPS Growth Forecast (3Y) | 22.83% |
Stock Splits
The last stock split was on December 23, 2025. It was a forward split with a ratio of 1.02.
| Last Split Date | Dec 23, 2025 |
| Split Type | Forward |
| Split Ratio | 1.02 |
Scores
Raia Drogasil has an Altman Z-Score of 3.66 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.66 |
| Piotroski F-Score | 6 |